INTERPARFUMS financials
INTERPARFUMS
Country: FR Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
969500SARWF33OPQED48 Financial statements
(EUR, as reported — unscaled; 104 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €899.4M | €880.5M |
| Cost of sales | €317.3M | €302.7M |
| Gross profit | €582.1M | €577.8M |
| Administrative expenses | €35.5M | €34.9M |
| Operating profit (EBIT) | €175.2M | €178.0M |
| Finance costs | €5.8M | €6.8M |
| Profit before tax | €166.0M | €174.3M |
| Income tax expense | €39.8M | €44.4M |
| Profit for the year | €127.0M | €130.3M |
| — attributable to owners | €126.6M | €129.9M |
| — attributable to NCI | €457.0K | €419.0K |
| Total comprehensive income | €119.1M | €134.3M |
| Per share | ||
| Basic EPS | €1.58 | €1.70 |
| Diluted EPS | €1.58 | €1.70 |
| Free cash flow / share | €1.64 | €1.37 |
| Cash flow statement | ||
| Cash generated from operations | €201.2M | €199.7M |
| Net cash from operating activities | €150.0M | €107.7M |
| Net cash from investing activities | -€41.6M | -€18.2M |
| Purchase of PP&E (capex) | €18.5M | €2.7M |
| Purchase of intangibles | €21.7M | €16.2M |
| Net cash from financing activities | -€87.7M | -€45.2M |
| Dividends paid | €87.6M | €80.3M |
| Proceeds from borrowings | €50.0M | €40.0M |
| Repayments of borrowings | €42.2M | €29.6M |
| Balance sheet | ||
| Total assets | €1.05B | €1.03B |
| Non-current assets | €453.2M | €436.6M |
| Property, plant & equipment | €154.3M | €143.8M |
| Right-of-use assets | €12.7M | €13.2M |
| Current assets | €596.2M | €596.4M |
| Inventories | €197.2M | €229.7M |
| Trade & other receivables | €168.5M | €164.2M |
| Cash & equivalents | €201.2M | €183.1M |
| Total equity | €731.7M | €698.6M |
| — attributable to owners | €730.0M | €697.0M |
| Non-controlling interests | €1.7M | €1.5M |
| Non-current liabilities | €115.5M | €118.0M |
| Long-term borrowings | €96.1M | €95.9M |
| Lease liabilities (non-current) | €7.8M | €10.8M |
| Current liabilities | €202.2M | €216.3M |
| Lease liabilities (current) | €3.2M | €3.2M |
| Deferred tax liabilities | €7.3M | €6.5M |
| Derived metrics | ||
| Free cash flow | €131.5M | €105.0M |
| Operating margin | 19.5% | 20.2% |
| Net margin | 14.1% | 14.8% |
| Return on equity | 17.4% | 18.7% |
| Cash conversion ratio | 1.18× | 0.83× |
| Capex coverage | 8.09× | 40.15× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €23.3M | -€19.3M |
| Adjustments For Decrease Increase In Other Operating Receivables | -€10.3M | -€1.1M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€12.5M | -€20.7M |
| Adjustments For Depreciation and Amortisation Expense | €30.6M | €22.5M |
| Adjustments For Income Tax Expense | €39.8M | €44.4M |
| Adjustments For Increase Decrease In Other Operating Payables | €6.8M | €7.5M |
| Adjustments For Increase Decrease In Trade Account Payable | -€3.4M | -€10.1M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €831.0K | €425.0K |
| Cash Flows From Used In Operations Before Changes In Working Capital | €146.0M | €151.4M |
| Comprehensive Income Attributable To Noncontrolling Interests | €457.0K | €419.0K |
| Comprehensive Income Attributable To Owners of Parent | €118.6M | €133.9M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €45.1M | €37.5M |
| Current Provisions | €0 | €0 |
| Current Tax Assets Current | €9.5M | €294.0K |
| Current Tax Liabilities Current | €1.5M | €8.0M |
| Deferred Tax Assets | €17.9M | €21.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€2.6M | €1.0M |
| Equity and Liabilities | €1.05B | €1.03B |
| Finance Income | €4.6M | €7.0M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | €386.0K | -€723.0K |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | €60.0K | €403.0K |
| Income Taxes Paid Refund Classified As Operating Activities | €54.0M | €47.9M |
| Increase Decrease In Cash and Cash Equivalents | €18.1M | €45.3M |
| Increase Decrease In Working Capital | -€4.0M | €43.7M |
| Increase Decrease Through Change In Equity of Subsidiaries | €2.1M | €0 |
| Increase Decrease Through Transfers and Other Changes Equity | -€19.0K | -€277.0K |
| Increase Decrease Through Treasury Share Transactions | -€439.0K | €1.2M |
| Intangible Assets Other Than Goodwill | €251.4M | €240.4M |
| Interest Paid Classified As Operating Activities | €1.2M | €430.0K |
| Investment Accounted For Using Equity Method | €13.2M | €12.9M |
| Issued Capital | €251.4M | €228.3M |
| Merger Reserve | €1.9M | €0 |
| Miscellaneous Other Operating Expense | €0 | €3.7M |
| Miscellaneous Other Operating Income | €0 | €3.5M |
| Noncurrent Provisions | €4.3M | €4.8M |
| Other Cash Payments To Acquire Interests In Joint Ventures Classified As Investing Activities | €2.0M | €0 |
| Other Comprehensive Income | -€7.9M | €4.0M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | €1.5M | -€2.8M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | -€9.2M | €4.9M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €232.0K | €1.6M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €1.1M | -€2.1M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€9.2M | €4.9M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €172.0K | €1.2M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€8.1M | €2.9M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €172.0K | €1.2M |
| Other Current Financial Assets | €3.3M | €7.6M |
| Other Current Liabilities | €55.7M | €62.3M |
| Other Current Receivables | €16.4M | €11.5M |
| Other Finance Cost | €29.1M | €13.1M |
| Other Finance Income | €21.0M | €9.1M |
| Other Inflows Outflows of Cash Classified As Financing Activities | -€4.6M | -€2.0M |
| Other Noncurrent Financial Assets | €897.0K | €2.7M |
| Other Reserves | €350.1M | €338.8M |
| Retained Earnings Profit Loss For Reporting Period | €126.6M | €129.9M |
| Sales and Marketing Expense | €371.4M | €364.6M |
| Share of Profit Loss of Joint Ventures Accounted For Using Equity Method | €831.0K | €425.0K |
| Trade and Other Current Payables To Trade Suppliers | €96.6M | €105.2M |
Methodology
Every line item above is a fact tagged in INTERPARFUMS's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.